Do We Have a Common Understanding of How Vaccine Policy Affects Health Equity? Evaluating Variability in the Advisory Committee on Immunization Practices' Equity Assessment.

BACKGROUND/OBJECTIVES: The Advisory Committee on Immunization Practices' (ACIP) Evidence to Recommendation (EtR) Framework has assessed vaccine equity, in addition to clinical and epidemiological data, since 2020. The domain's use has not yet been evaluated.

METHODS

Authors assessed web-published, Equity domain-inclusive ACIP Work Group EtR presentations occurring between October 2020 and October 2023. Domain judgments were scored and assigned variability ratings based on the number and spread of domain categories selected. Equity domain trends were evaluated using sample statistics and one- and two-way analyses of variance.

RESULTS

Of the 44 assessed EtRs, 27 (61.4%) had variable judgments for at least one domain; 9 (20.4%) had variable Equity judgments. Across domains, Values had the greatest variability, followed by Equity. Across disease targets, EtRs assessing products for RSV prevention were most variable. Pediatric product EtRs had greater variability than adult products, and EtRs resulting in shared clinical decision-making (SCDM) recommendations had greater variability than those resulting in routine recommendations.

CONCLUSIONS

Values and Equity domains judgment imprecision highlights a need for additional clarity to support consistent assessment.